Tokyo Tape
Sign in
← Fukuda Denshi

Half-year report · Q2

6960.TEDINET S100UR0K
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥64.3bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥140.3bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥66.5bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥10.7bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥14.0bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥11.3bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥27.0bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥14.1bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥11.4bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥14.3bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥7.7bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥18.7bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.8bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥7.7bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥9.8bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥204.8bnat 2024-09-30Cons.Assets
Total assets¥209.1bnat 2024-03-31Cons.Assets
Total assets¥210.8bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥32.8bnat 2024-09-30Cons.Liabilities
Total liabilities¥40.1bnat 2024-03-31Cons.Liabilities
Net assets / equity¥172.0bnat 2024-09-30Cons.Net assets
Net assets / equity¥169.0bnat 2024-03-31Cons.Net assets
Net assets / equity¥171.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥64.2bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥60.2bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥61.2bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥57.2bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥67.5bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥14.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥23.9bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥10.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥7.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥14.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥17.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥267.342024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥622.442023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥324.322023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio84.0%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio80.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.3%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥17.8bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥17.8bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.6bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2024-04-01 → 2024-09-30¥30.5bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2024-04-01 → 2024-09-30¥30.5bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2024-04-01 → 2024-09-30¥5.6bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2024-04-01 → 2024-09-30¥4.1bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2024-04-01 → 2024-09-30¥4.1bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2024-04-01 → 2024-09-30¥658m
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2024-04-01 → 2024-09-30¥11.9bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2024-04-01 → 2024-09-30¥11.9bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥64.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥64.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥10.7bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥20.5bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥20.5bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥4.1bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥29.3bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥29.3bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.7bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥3.8bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥3.8bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥737m
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥13.0bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.0bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥66.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥66.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥14.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 514
ItemContextValueUnit
Other noePrior1YTDDuration14000000JPY
Other noeCurrentYTDDuration9000000JPY
Non operating expensesPrior1YTDDuration100000000JPY
Non operating expensesCurrentYTDDuration29000000JPY
Ordinary incomePrior1YTDDuration14099000000JPY
Ordinary incomeCurrentYTDDuration11262000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration4000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration120000000JPY
Surrender value of insurance eiPrior1YTDDuration194000000JPY
Surrender value of insurance eiCurrentYTDDuration67000000JPY
Extraordinary incomePrior1YTDDuration199000000JPY
Extraordinary incomeCurrentYTDDuration188000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration5000000JPY
Loss on sales of noncurrent assets elCurrentYTDDuration34000000JPY
Impairment loss elPrior1YTDDuration4000000JPY
Impairment loss elCurrentYTDDuration6000000JPY
Office transfer expenses elPrior1YTDDuration8000000JPY
Office transfer expenses elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration18000000JPY
Extraordinary lossCurrentYTDDuration41000000JPY
Income before income taxesPrior1YTDDuration14280000000JPY
Income before income taxesCurrentYTDDuration11410000000JPY
Income taxes currentPrior1YTDDuration4286000000JPY
Income taxes currentCurrentYTDDuration3215000000JPY
Income taxes deferredPrior1YTDDuration183000000JPY
Income taxes deferredCurrentYTDDuration487000000JPY
Income taxesPrior1YTDDuration4469000000JPY
Income taxesCurrentYTDDuration3703000000JPY
Profit lossPrior1YTDDuration9810000000JPY
Profit lossCurrentYTDDuration7706000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration9810000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration7706000000JPY
Profit lossPrior1YTDDuration9810000000JPY
Profit lossCurrentYTDDuration7706000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration1372000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-1519000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration310000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration-108000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-19000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-63000000JPY
Other comprehensive incomePrior1YTDDuration1664000000JPY
Other comprehensive incomeCurrentYTDDuration-1691000000JPY
Comprehensive incomePrior1YTDDuration11474000000JPY
Comprehensive incomeCurrentYTDDuration6014000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration11474000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration6014000000JPY
Income before income taxesPrior1YTDDuration14280000000JPY
Income before income taxesCurrentYTDDuration11410000000JPY
Depreciation and amortization ope cfPrior1YTDDuration4611000000JPY
Depreciation and amortization ope cfCurrentYTDDuration5139000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass